pharmaphorum
SEPTEMBER 15, 2021
The European Commission is reportedly in advanced discussions with French biotech Valneva about picking up the contract to supply COVID-19 vaccines that was terminated by the UK government this week. A French government source told Reuters that the EU is considering using the VLA2001 vaccine as part of its booster campaign plans, along with a shot from Sanofi and GlaxoSmithKline.
Pharma Times
SEPTEMBER 15, 2021
Researchers discovered that treating mice with broad-spectrum antibiotics increased the rate at which their breast cancer tumours grew
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
SEPTEMBER 14, 2021
Annual Drug Patent Expirations for ANORO+ELLIPTA Anoro Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fourteen patents…. The post New patent for Glaxosmithkline drug ANORO ELLIPTA appeared first on DrugPatentWatch - Make Better Decisions.
Outsourcing Pharma
SEPTEMBER 14, 2021
The pharma tech firm has forged a four-year partnership with the foundation to develop antivirals for COVID-19 and other viruses with pandemic potential.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
SEPTEMBER 12, 2021
Deployment of digital health technologies during the pandemic improved patient satisfaction, expanded the delivery of care and augmented training of staff at a leading neurosurgery provider in the US, according to a new study. Faced with the disruption caused by the COVID-19 crisis, Cleveland Clinic centres implemented a number telehealth and audio-visual technologies to compensate for the difficulties in having face-to-face interactions with patients.
Pharma Times
SEPTEMBER 16, 2021
Through Entia’s virtual oncology platform, patients are able to perform their own blood tests
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Mirror
SEPTEMBER 16, 2021
What is a health coach? A health coach is someone with expertise in wellness who assists people achieve good health by being a mentor and educator on lifestyle and nutritional changes. It is important to understand that health coaching is not only about nutrition, but instead, health coaches offer people a holistic approach to creating and sustaining healthy habits.
pharmaphorum
SEPTEMBER 15, 2021
Researchers in the UK are working on an artificial intelligence (AI) algorithm to help diagnose deep vein thrombosis (DVT) from ultrasound images – and potentially prevent patients from receiving drugs unnecessarily. The team from Oxford University, Imperial College London and the University of Sheffield are working with German tech company ThinkSono on the smartphone-based app, called AutoDVT, and estimate it could cut the cost to health services of each examination by up to $150.
Outsourcing Pharma
SEPTEMBER 16, 2021
The US agency has given the go-ahead to Cour Pharmaceuticals to evaluate the safety and efficacy of CNP-201, a drug intended to treat peanut allergies.
Drug Patent Watch
SEPTEMBER 15, 2021
Annual Drug Patent Expirations for ENTRESTO Entresto is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. There are nine…. The post New patent for Novartis Pharms drug ENTRESTO appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
NY Times
SEPTEMBER 17, 2021
The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination.
pharmaphorum
SEPTEMBER 16, 2021
Takeda has had a run of bad luck with its Wave1 pipeline of new drug candidates of late, but can now celebrate a vestry after getting FDA approval for first-in-class lung cancer therapy Exkivity. The US regulator has cleared the tyrosine kinase inhibitor (TKI) as a second-line treatment for locally advanced or metastatic non-small-cell lung cancer (NSCLC) patients whose tumours have EGFR exon20 insertion mutations, after first-line chemotherapy.
Outsourcing Pharma
SEPTEMBER 13, 2021
The two companies are collaborating on development of Myfembree, a combination therapy to treat the painful condition affecting millions of women worldwide.
Pharma Times
SEPTEMBER 13, 2021
AZ’s combo treatment reduced the risk of disease progression or death by 28% compared to chemotherapy alone
NY Times
SEPTEMBER 11, 2021
At least 21 percent of nursing home residents are on antipsychotic drugs, a Times investigation found.
pharmaphorum
SEPTEMBER 14, 2021
The first patient has received a low dose of Beckley Psytech’s psychedelic medicine psilocybin in a clinical trial for short-lasting unilateral neuralgiform headache attacks (SUNHA), a rare disorder. The UK company says that SUNHA is a debilitating condition that is estimated to affect 40,000 patients in US and Europe. It is characterised by short, extremely painful headaches that can occur many times a day, and there is currently no approved treatment for the condition.
Outsourcing Pharma
SEPTEMBER 13, 2021
The advocacy organization's PIE4CNS initiative is aimed at targeting and reducing gaps in diagnosis, research, and trials for rare neurological conditions.
Pharma Times
SEPTEMBER 13, 2021
The Galleri test is able to identify the ‘earliest’ signs of cancer in the blood
Drug Channels
SEPTEMBER 14, 2021
On October 5, 2021, Drug Channels Institute will release The 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. This report—our twelfth edition— remains the most comprehensive, fact-based tool for understanding and analyzing the large and growing U.S. pharmaceutical distribution industry. We are providing you with the opportunity to preorder this thoroughly updated and revised 2021-22 edition at special discounted prices.
pharmaphorum
SEPTEMBER 14, 2021
There has been a fourth patient fatality in Astellas’ clinical trial of its AT132 gene therapy for the rare disease X-linked myotubular myopathy (XLMTM), which has been halted twice due to safety concerns. The latest suspension came after abnormal liver function tests (LFTs) were seen in a boy receiving the gene therapy, who has since passed away, according to a statement issued today by the Japanese drugmaker.
Outsourcing Pharma
SEPTEMBER 16, 2021
Stakeholders in the Rare Disease Cures Accelerator-Data and Analytics Platform initiative are partnering in hopes of bringing treatments to patients faster.
Pharma Times
SEPTEMBER 17, 2021
177Lu-PSMA-617 is being evaluated for the treatment of metastatic castration-resistant prostate cancer
Drug Channels
SEPTEMBER 15, 2021
Sometimes, a little knowledge can be a bad thing. I want to share with you, dear reader, the strange but true tale of my recent foray into the wonderful world of hospital price transparency for routine lab services. I discovered—with great effort—that the rates my health plan negotiated with the largest local health system in Philadelphia were greater than the self-pay, cash price.
pharmaphorum
SEPTEMBER 15, 2021
Not enough is being done to ensure that patient voices are included in policymaking around digital health, says a new patient organisation in the UK, which aims to set that situation right. The Patient Coalition for AI, Data and Digital Tech in Health has brought together members of patient organisations, medical colleges and health charities to tackle issues such as ensuring equitable access to digital health services.
Outsourcing Pharma
SEPTEMBER 14, 2021
A survey commissioned by Bristol Myers Squibb reveals healthcare providers are confident that immunotherapy can positively impact earlier-stage cancers.
Pharma Times
SEPTEMBER 17, 2021
Approximately 1,000 people will be eligible for the treatment in England
Drug Channels
SEPTEMBER 17, 2021
Today’s guest post comes from Vicki Muscarella, Vice President of Specialty at CoverMyMeds. Vicki discusses the advantages of integrated technology solutions in enhancing specialty patients' access to therapy, affordability, and adherence. CoverMyMeds now includes RelayHealth, RxCrossroads by McKesson, and McKesson Prescription automation. Click here to sign up for complimentary early access to the specialty edition of the CoverMyMeds 2021 Medication Access Report.
pharmaphorum
SEPTEMBER 16, 2021
Given the rising cost of medicines as a share of the NHS budget in England, the establishment of ICSs provides a timely opportunity to take stock on delivering medicines optimisation at local level, says NHS Gloucestershire CCG’s Ellen Rule. Medicines optimisation aims to improve health outcomes, service quality, and sustainability by ensuring patients are taking their prescribed medicines as recommended to derive the intended benefits and avoid incurring harms.
Outsourcing Pharma
SEPTEMBER 14, 2021
A physician assistant from Hawthorne Effect shares how she and other trained health professionals contribute their knowledge and talents to in-home studies.
Pharma Times
SEPTEMBER 14, 2021
Phase Ib trial is evaluating the potential benefit of low-dose psilocybin as a treatment for SUNHA
Drug Channels
SEPTEMBER 13, 2021
Informa Connect’s Drug Pricing Transparency Congress. Delivered as a Hybrid Event In-Person: November 9-10 | Philadelphia, PA Virtual: November 16-17 www.informaconnect.com/drug-pricing-transparency. Save 10% by using code 21DPT10. The 2021 Drug Pricing Transparency Congress , an important event dedicated to providing critical updates on federal and state reporting requirements, policy initiatives and strategic best practices for compliance, returns this November as a HYBRID event, with the in-p
pharmaphorum
SEPTEMBER 14, 2021
If there was an AI solution in the Life Sciences field, able to represent a real opportunity in terms of Customer Engagement and Digital Transformation, and if some of the most important players in the industry already had it, would you like to have the opportunity to listen to them? . . This and other trend topics, will be discussed on September 29th , at the digital event “ AI as Business Leverage in Pharma & Life Sciences Industries ” by Trueblue , an Italian IT company that
Outsourcing Pharma
SEPTEMBER 16, 2021
This monthâs roundup of new technology, equipment, and industry partnerships includes news from IBM, IQVIA, Mediata, Labcorp, and other notable companies.
Pharma Times
SEPTEMBER 14, 2021
Children in this age group will be offered one dose of the Pfizer/BioNTech jab from next week
Drug Patent Watch
SEPTEMBER 17, 2021
Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Veloxis Pharms drug ENVARSUS XR appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
113 
Let's personalize your content